Ai Biopharma Cost Modeling

Economics Of Pharmaceutical Innovation

Doctoral research examines the economic structures shaping how medicines are discovered and developed. Understanding these structures is prerequisite to any credible estimate of development expenditure.

Research And Development Cost Estimation

Research investigates methods for estimating the resources consumed in bringing a medicine to market. Estimates from this work anchor policy debate on medicine pricing worldwide.

Capitalised Cost Methodology

Doctoral study addresses inclusion of the time value of committed capital in development estimates. Capitalisation choices account for much of the disagreement between published estimates.

Cost Of Capital In Drug Development

Research examines the required return investors demand for funding uncertain development. This rate strongly influences every present value calculation in the sector.

Attrition Rates And Expected Expenditure

Doctoral work studies how programme failure rates determine the resources consumed per approval. Failure absorbs the majority of total sector development spending.

Success Probability Estimation

Research investigates estimation of the chance a programme reaches approval. Probability estimates drive both investment decisions and aggregate cost figures.

Phase Transition Probability Modelling

Doctoral study addresses estimation of advancement between successive development stages. Transition probabilities are the fundamental input to any development model.

Time To Market Modelling

Research examines the duration from discovery to authorisation and its determinants. Duration affects both capitalised expenditure and remaining exclusivity.

Development Timeline And Expenditure Interaction

Doctoral work studies how acceleration or delay changes total programme expenditure. Timeline and resource use cannot be optimised independently of each other.

Portfolio Level Cost Modelling

Research investigates resource modelling across a set of concurrent programmes. Portfolio effects differ substantially from summing individual programme estimates.

Risk Adjusted Present Value Methods

Doctoral study addresses valuation incorporating both timing and probability of success. This approach is the standard basis for programme investment decisions.

Real Options Analysis In Development

Research examines valuation treating development stages as sequential decision points. Options framing captures the value of being able to abandon a programme.

Decision Tree Modelling Of Programmes

Doctoral work studies structured representation of development choices and outcomes. Tree models make the consequences of stage decisions explicit.

Simulation Of Development Expenditure

Research investigates probabilistic simulation of resource consumption across programmes. Simulation reveals the full distribution rather than a single expected figure.

Sensitivity Analysis In Cost Models

Doctoral study addresses identification of which assumptions drive model conclusions. Sensitivity analysis distinguishes robust findings from assumption artefacts.

Scenario Modelling For Programmes

Research examines structured comparison of distinct plausible development futures. Scenario analysis addresses uncertainty that point estimates entirely conceal.

Uncertainty Quantification In Cost Estimates

Doctoral work studies honest expression of confidence in estimated development expenditure. Published estimates are frequently reported without any uncertainty at all.

Bias In Reported Development Costs

Research investigates systematic distortion in publicly available cost figures. Estimates originate largely from parties with an interest in their magnitude.

Data Sources For Cost Research

Doctoral study addresses the datasets available for studying development expenditure. Data access is the binding constraint on independent cost research.

Transparency In Cost Disclosure

Research examines what developers reveal about programme expenditure and why. Disclosure practice determines whether independent verification is possible at all.

Comparative Cost Across Therapeutic Areas

Doctoral work studies differences in development expenditure between disease areas. Area differences reflect trial size, duration and failure rates jointly.

Cost Differences By Product Modality

Research investigates how development expenditure varies across therapeutic technologies. Modality differences are widening as new technology classes mature.

Small Molecule Development Economics

Doctoral study addresses the economics of conventional chemically synthesised medicines. This class carries the longest evidence base for development expenditure.

Biologic Development Economics

Research examines the distinctive economics of protein and antibody therapeutics. Manufacturing complexity shifts the balance between development and production expenditure.

Cell And Gene Therapy Economics

Doctoral work studies economics of therapies manufactured for or from individual patients. These products break the assumptions underlying conventional cost models.

Vaccine Development Economics

Research investigates the economics of preventive immunisation products. Vaccine economics combines low unit revenue with very large public benefit.

Antimicrobial Development Economics

Doctoral study addresses why antimicrobial development is commercially unattractive. Conservation of new agents directly conflicts with recovering development expenditure.

Rare Disease Development Economics

Research examines economics of products for very small patient populations. Small populations force distinctive approaches to both trials and pricing.

Paediatric Development Economics

Doctoral work studies the additional expenditure required for use in children. Paediatric requirements are mandated yet rarely commercially attractive.

Repurposing And Reformulation Economics

Research investigates the economics of developing new indications for already established medicines. Repurposing reduces development expenditure but complicates both protection and pricing considerably.

Discovery Stage Cost Structure

Doctoral study addresses resource consumption during early target and candidate molecule identification. Discovery expenditure is modest per programme but is repeated across very many failures.

Target Identification Cost Efficiency

Research examines the resources required to establish a validated biological target. Target choice determines the failure risk of everything that follows.

Screening Campaign Economics

Doctoral work studies resource use in large molecular screening programmes against chosen targets. Screening economics changed substantially once computational prefiltering became practical.

Lead Optimisation Resource Use

Research investigates iterative chemical refinement of candidate molecules and its resource demands. Optimisation cycles dominate both the duration and expenditure of the discovery phase.

Preclinical Study Cost Modelling

Doctoral study addresses expenditure on laboratory and animal studies before human use. Preclinical requirements are substantial and largely fixed by regulation.

Toxicology Programme Costs

Research examines resource use in safety studies required before human exposure. Toxicology programmes are among the largest single preclinical expenses.

Animal Study Cost And Replacement

Doctoral work studies expenditure on animal testing and the economics of replacing it. Replacement methods must be economically as well as scientifically viable.

Clinical Trial Cost Drivers

Research investigates the factors determining what human studies actually consume. Trials account for the majority of total development expenditure.

Per Patient Trial Cost Analysis

Doctoral study addresses expenditure attributable to each enrolled participant. Per patient figures permit comparison across trials of differing size.

Site Selection And Cost

Research examines how choice of investigating centres affects trial expenditure. Site choice affects recruitment speed, quality and unit expenditure together.

Patient Recruitment Cost Modelling

Doctoral work studies expenditure on identifying and enrolling eligible participants. Recruitment difficulty is a leading cause of trial expenditure overrun.

Retention And Protocol Compliance Costs

Research investigates resources consumed keeping participants in a study to completion. Loss of participants both raises expenditure and weakens conclusions.

Protocol Complexity And Cost

Doctoral study addresses how the number of procedures and endpoints affects expenditure. Protocol complexity has risen steadily with measurable cost consequences.

Trial Design Efficiency Analysis

Research examines designs achieving equivalent evidence with fewer resources. Design efficiency is the most controllable determinant of trial expenditure.

Adaptive Trial Economics

Doctoral work studies the resource implications of designs that adjust during conduct. Adaptive designs reduce expected expenditure while raising operational complexity.

Platform Trial Cost Sharing

Research investigates shared infrastructure across multiple simultaneous investigations. Shared platforms distribute fixed expenditure across several candidates.

Decentralised Trial Cost Effects

Doctoral study addresses expenditure implications of conducting studies outside traditional sites. Remote conduct shifts rather than simply reduces resource requirements.

Digital Endpoint Cost Implications

Research examines expenditure effects of measurement using connected devices. Digital measurement changes both data volume and validation requirements.

Real World Evidence Generation Costs

Doctoral work studies resources required to produce evidence from routine care data. Real world studies are cheaper than trials but carry different requirements.

External Control Arm Economics

Research investigates comparison groups drawn from existing data rather than randomised. External controls reduce enrolment requirements but face acceptance obstacles.

Contract Research Organisation Pricing

Doctoral study addresses how outsourced clinical services are priced and negotiated. Outsourcing accounts for a large share of trial expenditure.

Trial Monitoring Cost Models

Research examines expenditure on oversight of investigating sites and data quality. Risk based monitoring approaches substantially changed this expenditure.

Data Management Cost Analysis

Doctoral work studies resources consumed collecting, cleaning and preparing trial data. Data activities are a persistent and underexamined expenditure category.

Regulatory Submission Costs

Research investigates resources required to prepare and file applications for authorisation. Submission preparation consumes substantial expertise over extended periods.

Regulatory Interaction Cost Modelling

Doctoral study addresses expenditure arising from engagement with authorities during development. Regulatory requirements discovered late are the most expensive to satisfy.

Post Approval Study Obligations

Research examines studies required as a condition of continued authorisation. These obligations extend development expenditure well past first approval.

Pharmacovigilance Cost Structures

Doctoral work studies resources required for ongoing safety monitoring of marketed products. Safety monitoring obligations continue for the life of a product.

Risk Management Programme Costs

Research investigates expenditure on controlled distribution and safety programmes. These programmes affect both cost and patient access to a product.

Multiregional Development Cost Modelling

Doctoral study addresses expenditure on development spanning several regulatory regions. Simultaneous global development multiplies both complexity and requirement.

Local Requirement Cost Burden

Research examines additional expenditure imposed by nation specific requirements. Local requirements can determine whether a market is entered at all.

Manufacturing Cost Modelling

Doctoral work studies estimation of production expenditure across product types. Production expenditure determines achievable margin and access pricing.

Cost Of Goods Analysis

Research investigates the direct resources consumed producing each unit of product. This figure sets a floor beneath any sustainable pricing arrangement.

Process Economics In Bioprocessing

Doctoral study addresses the economics of biological manufacturing operations. Bioprocess economics differ fundamentally from chemical synthesis economics.

Upstream Process Cost Drivers

Research examines resource consumption during cell culture and fermentation stages. Upstream productivity determines the scale required for downstream operations.

Downstream Purification Economics

Doctoral work studies expenditure on separation and purification operations. Purification frequently dominates biological production expenditure.

Yield Improvement Economics

Research investigates the return achieved from process productivity improvements. Yield gains propagate through the whole production cost structure.

Batch And Continuous Process Comparison

Doctoral study addresses economic comparison of discrete and continuous production modes. Continuous operation promises lower expenditure with higher development requirement.

Single Use Technology Economics

Research examines economics of disposable rather than fixed production equipment. Disposable systems trade consumable expenditure against capital and cleaning.

Facility Design And Capital Requirement

Doctoral work studies the capital committed in building production facilities. Facility decisions commit resources for decades ahead of demand certainty.

Facility Utilisation Modelling

Research investigates how effectively production capacity is actually used. Utilisation determines the fixed expenditure allocated to each unit produced.

Capacity Planning Under Uncertainty

Doctoral study addresses capacity decisions made before demand is known. Both shortage and idle capacity carry substantial economic consequences.

Technology Transfer Cost Analysis

Research examines expenditure moving a process between sites or organisations. Transfer is routinely underestimated and frequently causes delay.

Scale Up Cost Modelling

Doctoral work studies expenditure moving from development to commercial production scale. Scale up problems are a leading cause of launch delay.

Quality Control Cost Structures

Research investigates resources consumed by testing and release activities. Quality expenditure is largely fixed by regulation rather than by choice.

Batch Failure And Rework Costs

Doctoral study addresses economic consequences of production runs that fail specification. Failed batches of biological products represent very large losses.

Deviation And Investigation Costs

Research examines expenditure arising from departures from approved procedures. Investigation burden is a substantial hidden expenditure in regulated manufacture.

Compliance Cost In Manufacture

Doctoral work studies resources required to maintain regulatory compliance in production. Compliance expenditure is disproportionately burdensome for smaller producers.

Raw Material Cost Volatility

Research investigates variability in input material expenditure and its management. Input volatility transmits directly into production expenditure.

Supplier Concentration And Cost Risk

Doctoral study addresses dependence on few suppliers for critical inputs. Concentration creates both pricing exposure and supply interruption risk.

Supply Chain Cost Modelling

Research examines expenditure across the full route from production to patient. Supply expenditure is frequently invisible in product level analysis.

Cold Chain Cost Analysis

Doctoral work studies expenditure maintaining temperature control through distribution. Temperature requirements determine which markets can be served at all.

Distribution Network Optimisation

Research investigates network design minimising total distribution expenditure. Network structure affects both expenditure and reliability of supply.

Inventory Policy And Working Capital

Doctoral study addresses the capital committed in held stock across the chain. Inventory decisions balance shortage risk against committed capital.

Shortage Cost Estimation

Research examines the economic and health consequences of supply interruption. Shortage consequences are borne by health systems rather than producers.

Resilience Investment Economics

Doctoral work studies the return from investment in supply robustness. Resilience investment is difficult to justify against expenditure minimisation alone.

Regional Production Economics

Research investigates the economics of manufacturing closer to consuming markets. Regional production trades unit expenditure against supply security.

Contract Manufacturing Economics

Doctoral study addresses economics of production by external organisations. Outsourced production dominates the sector for many product types.

Make Or Buy Decision Modelling

Research examines choice between internal and external production capability. This decision commits organisational capability for many years.

Cell Therapy Manufacturing Economics

Doctoral work studies production economics for individually manufactured therapies. Per patient manufacture eliminates the scale economies conventional products enjoy.

Personalised Product Cost Structures

Research investigates expenditure structures where each unit is unique. Personalisation reverses the economics on which the sector was built.

Automation Investment Appraisal

Doctoral study addresses evaluation of automation in production and laboratories. Automation trades capital commitment against ongoing labour expenditure.

Digital Manufacturing Cost Benefit

Research examines returns from digital monitoring and control in production. Digital investment claims frequently lack rigorous economic evaluation.

Energy And Utility Cost Modelling

Doctoral work studies expenditure on energy, water and clean utilities in production. Utility expenditure is substantial in facilities requiring controlled environments.

Environmental Cost Internalisation

Research investigates incorporation of environmental effects into production accounting. Internalisation changes the relative economics of production routes.

Waste And Disposal Cost Analysis

Doctoral study addresses expenditure managing waste from production and clinical use. Disposal requirements for certain products are unusually demanding.

Health Technology Assessment Methods

Research examines structured evaluation of whether a therapy justifies its expenditure. Assessment outcomes determine access in most publicly funded systems.

Cost Effectiveness Analysis

Doctoral work studies comparison of therapies by expenditure per unit of health gained. This framework underpins reimbursement decisions across many countries.

Cost Utility Analysis Methods

Research investigates evaluation using outcomes adjusted for quality of life. Utility based comparison permits evaluation across entirely different conditions.

Quality Adjusted Outcome Measurement

Doctoral study addresses measurement combining survival and health related quality. These measures are influential and persistently contested methodologically.

Budget Impact Analysis

Research examines the total expenditure consequence of adopting a therapy. Budget impact frequently determines decisions more than efficiency measures do.

Decision Analytic Modelling In Health

Doctoral work studies formal models comparing health interventions over time. These models extrapolate well beyond the evidence trials provide.

Markov Model Construction

Research investigates state transition models of disease and treatment progression. This structure is the most widely used in economic evaluation.

Discrete Event Simulation In Health Economics

Doctoral study addresses individual level simulation of patient pathways through care over time. Event simulation represents interactions and history that simpler state models cannot capture.

Survival Extrapolation Methods

Research examines projection of survival beyond the observed trial period. Extrapolation assumptions frequently dominate the resulting conclusions.

Utility Value Elicitation

Doctoral work studies measurement of how people value different health states. Elicitation method choice materially changes evaluation outcomes.

Discounting In Economic Models

Research investigates the treatment of future costs and benefits relative to present ones. The discount rate strongly affects preventive and curative comparisons.

Perspective Selection In Economic Evaluation

Doctoral study addresses whose costs and benefits an evaluation counts. Perspective choice determines whether wider effects enter the analysis.

Indirect And Productivity Cost Measurement

Research examines effects of illness and treatment on work capacity, caring and unpaid activity. These effects are frequently large yet excluded entirely from narrow health system evaluations.

Cost Data Collection Methods

Doctoral work studies gathering resource use information alongside clinical studies. Collection method determines the reliability of every subsequent estimate.

Unit Cost Estimation Methods

Research investigates the valuation of individual health service resources such as visits and procedures. Unit values determine whether analyses can be compared across settings and countries at all.

Micro Costing Approaches

Doctoral study addresses detailed measurement of individual resource components. Micro costing gives precision at substantial data collection expense.

Administrative Data For Cost Analysis

Research examines use of routine billing and activity records in economic research. Administrative records offer scale with substantial recording bias.

Machine Learning In Cost Prediction

Doctoral work studies learned models forecasting resource use for individuals. Prediction supports both planning and risk based payment arrangements.

Patient Level Cost Modelling

Research investigates modelling resource use at individual rather than cohort level. Individual modelling captures heterogeneity that averages conceal.

Heterogeneity In Cost Effectiveness

Doctoral study addresses variation in economic value across different patient subgroups. Average results can conceal populations for whom a therapy represents very poor value.

Subgroup Analysis In Economic Evaluation

Research examines evaluation restricted to defined patient populations. Subgroup analysis supports targeted rather than blanket reimbursement.

Value Of Information Analysis

Doctoral work studies whether further research would be worth its expenditure. This analysis directs research funding toward decision relevant uncertainty.

Threshold Analysis For Reimbursement

Research investigates the value boundary at which funding decisions change. Threshold choice embeds a judgement about acceptable health expenditure.

Willingness To Pay Estimation

Doctoral study addresses measurement of what society will commit for health gain. These estimates underpin the thresholds reimbursement bodies apply.

Pricing Strategy Modelling

Research examines how developers set, justify and defend the pricing of their products. Pricing decisions determine patient access and the return realised on development investment.

Value Based Pricing Approaches

Doctoral work studies pricing arrangements linked explicitly to demonstrated health benefit. Value based approaches attempt to align developer incentives with the outcomes patients experience.

Reference Pricing Systems

Research investigates pricing determined by reference to comparable products or to other countries. Reference systems propagate a single pricing decision across many national markets.

International Price Comparison Methods

Doctoral study addresses methodological difficulty in comparing pricing across countries. Confidential arrangements make published comparisons largely unreliable.

Confidential Discount Arrangements

Research examines undisclosed reductions negotiated away from published list pricing. Confidentiality undermines international comparison and public accountability simultaneously.

Managed Entry Agreements

Doctoral work studies conditional funding arrangements reducing payer risk. These agreements permit access while evidence is still developing.

Outcome Based Contracting

Research investigates payment arrangements linked to the results actually achieved in practice. Outcome contracts shift performance risk from the purchaser toward the developer.

Instalment Payment Models

Doctoral study addresses spreading payment for one time curative therapies. Payment spreading addresses budget effects of very high one time expenditure.

Subscription Payment Models

Research examines arrangements paying for guaranteed access rather than for units actually supplied. Subscription models separate developer revenue from the volume of product consumed.

Tiered Pricing Across Markets

Doctoral work studies pricing differentiated according to the economic capacity of each country. Tiering supports wider access while creating risk of product movement between markets.

Generic Entry And Market Dynamics

Research investigates market behaviour following loss of exclusivity. Generic entry produces the largest expenditure reductions in the sector.

Biosimilar Market Economics

Doctoral study addresses competition among follow on biological products. Biosimilar competition behaves quite differently from small molecule competition.

Exclusivity And Market Protection Effects

Research examines how protection periods affect pricing and expenditure. Protection duration is the principal policy lever over sector returns.

Patent Expiry Modelling

Doctoral work studies revenue and expenditure consequences of protection ending. Expiry effects drive both corporate strategy and health budgets.

Launch Sequencing Economics

Research investigates the order in which national markets are entered following approval. Sequencing decisions are shaped heavily by reference pricing linkages between countries.

Market Uptake Forecasting

Doctoral study addresses prediction of how quickly a therapy is adopted. Uptake forecasts drive both production planning and budget impact estimates.

Reimbursement Decision Processes

Research examines how funding bodies reach coverage decisions in practice. Process design determines what evidence actually influences outcomes.

Payer Decision Modelling

Doctoral work studies formal representation of how purchasers reach funding decisions. Payer models inform developer strategy and determine which evidence is generated.

Formulary Management Analysis

Research investigates how lists of funded medicines are constructed and revised. Formulary position determines clinical use more than approval does.

Procurement And Tendering Economics

Doctoral study addresses competitive purchasing arrangements for medicines. Tender design determines both achieved pricing and supply reliability.

Pooled Procurement Mechanisms

Research examines joint purchasing across institutions or countries. Pooling improves bargaining position for smaller purchasers substantially.

Health System Affordability Analysis

Doctoral work studies whether health systems can sustain new therapy expenditure. Affordability questions differ from efficiency questions fundamentally.

Opportunity Cost In Health Budgets

Research investigates what other care is forgone when a new therapy is funded from a fixed budget. Constrained budgets mean every funding decision necessarily displaces something already provided.

Displacement Effects Of New Therapies

Doctoral study addresses which existing services are reduced to fund new ones. Displacement is rarely measured despite being certain to occur.

Equity Considerations In Economic Evaluation

Research examines distribution of health gains alongside their total magnitude. Standard evaluation treats a gain identically regardless of recipient.

Distributional Cost Effectiveness Analysis

Doctoral work studies evaluation explicitly incorporating equity effects. Distributional methods make trade offs between efficiency and fairness visible.

Access In Low Income Settings

Research investigates affordability and availability where health resources are minimal. Most of the world faces access constraints unlike those in wealthy systems.

Differential Pricing And Access

Doctoral study addresses pricing arrangements intended to widen global access. Differential pricing depends on preventing arbitrage between markets.

Voluntary Licensing Economics

Research examines agreements permitting others to produce protected medicines. Voluntary licensing has substantially widened access for several products.

Compulsory Licensing Analysis

Doctoral work studies state authorised production without holder consent. This mechanism is rarely used but shapes negotiation substantially.

Local Production Economics

Research investigates the economics of manufacturing within consuming countries. Local production promises security at frequently higher unit expenditure.

Public Funding Of Research And Development

Doctoral study addresses the public contribution to medicine development. Public funding underpins much of the science later developed commercially.

Return On Public Investment Analysis

Research examines what public research funding delivers economically. Return estimates inform arguments about pricing of publicly derived products.

Push And Pull Incentive Mechanisms

Doctoral work studies instruments encouraging development of neglected products. Incentive design determines which unmet needs attract development.

Prize And Milestone Reward Models

Research investigates rewards paid for achievement rather than through sales. Reward models separate innovation incentive from product pricing.

Advance Purchase Commitment Analysis

Doctoral study addresses guaranteed future purchase as a development incentive. Commitments reduce market risk for products with uncertain demand.

Priority Review Incentive Economics

Research examines regulatory incentives granted for developing neglected products. Transferable incentives create markets with their own dynamics.

Orphan Designation Incentive Analysis

Doctoral work studies incentives for products treating very rare conditions. These incentives have reshaped development priorities substantially.

Antimicrobial Incentive Mechanisms

Research investigates arrangements sustaining antimicrobial development despite conservation. Conventional market mechanisms fail comprehensively for these products.

Pandemic Preparedness Financing

Doctoral study addresses funding arrangements for products needed only in emergencies. Preparedness requires payment for capability that may never be used.

Emergency Procurement Economics

Research examines how medicines and vaccines are purchased during declared health emergencies. Emergency conditions suspend the normal economics and safeguards of medicine procurement.

Separation Of Revenue From Volume

Doctoral work studies models that decouple developer return from the quantity of product sold. Decoupling addresses products such as antimicrobials where use should deliberately be minimised.

Nonprofit Development Models

Research investigates development conducted without commercial return objectives. These models address needs that commercial development ignores.

Product Development Partnership Economics

Doctoral study addresses collaborative development arrangements for neglected diseases. Partnerships combine public, philanthropic and commercial resources.

Philanthropic Funding Analysis

Research examines the role and effects of charitable funding in development. Philanthropic funding shapes priorities in areas commercial funding avoids.

Financing Structures For Development

Doctoral work studies instruments raising capital for medicine development. Financing structure determines which programmes can be pursued at all.

Venture Investment Patterns

Research investigates where early stage investment concentrates and the reasons for that concentration. Investment patterns determine which scientific areas ever reach clinical development at all.

Merger And Acquisition Valuation

Doctoral study addresses valuation of companies and pipelines in transactions. Acquisition is the dominant route by which innovation reaches scale.

Licensing Deal Valuation

Research examines valuation of rights transferred between organisations. Deal structures allocate both risk and return across development stages.

Milestone And Royalty Structure Analysis

Doctoral work studies staged payment arrangements in development agreements. Structure determines cash flow timing for both parties involved.

Collaboration Cost Sharing Models

Research investigates division of expenditure in joint development arrangements. Sharing arrangements determine control as well as financial exposure.

Cost Data Standards And Interoperability

Doctoral study addresses common formats for health resource and expenditure data. Standards determine whether analyses can be compared or combined.

Claims Database Analysis Methods

Research examines analytical use of insurance and reimbursement records. Claims data offers scale with well documented measurement limitations.

Electronic Record Based Cost Research

Doctoral work studies economic analysis using clinical record systems. Clinical records capture activity that billing records omit entirely.

Registry Data For Economic Analysis

Research investigates disease and treatment registries as data sources for economic evaluation. Registries provide the extended follow up period that clinical trials cannot practically supply.

Data Linkage For Cost Studies

Doctoral study addresses joining datasets to follow patients across services. Linkage reveals expenditure that single source analysis misses.

Missing Data Handling In Cost Analysis

Research examines statistical treatment of incomplete resource use records. Missing resource data is pervasive and rarely missing at random.

Skewed Cost Distribution Modelling

Doctoral work studies statistical methods for highly asymmetric expenditure data. Health expenditure distributions defeat standard statistical assumptions.

Censoring In Cost Data

Research investigates incomplete follow up in economic evaluation alongside trials. Censoring in expenditure data requires methods distinct from survival analysis.

Causal Inference In Cost Evaluation

Doctoral study addresses estimating causal effects on resource use from observational data. Most economic questions cannot be addressed by randomisation.

Instrumental Variable Methods In Health Economics

Research examines causal estimation using variables affecting treatment but not outcome. These methods address the confounding that pervades health data.

Difference In Differences Applications

Doctoral work studies evaluation of policy changes using before and after comparison. Policy changes provide natural experiments for economic evaluation.

Natural Experiment Analysis

Research investigates exploitation of unplanned variation for causal estimation. Natural experiments provide evidence where trials are impossible.

Model Validation In Health Economics

Doctoral study addresses confirmation that economic models behave defensibly. Validation practice in this field remains inconsistent and informal.

Model Transparency And Reporting Standards

Research examines disclosure requirements for economic model structure and inputs. Opaque models cannot be scrutinised by those affected by their conclusions.

Reproducibility In Economic Modelling

Doctoral work studies whether published economic analyses can be regenerated. Model code and inputs are frequently withheld from independent review.

Open Source Health Economic Models

Research investigates openly published and modifiable evaluation models. Open models permit scrutiny and reuse that proprietary models prevent.

Automation Of Model Construction

Doctoral study addresses computational assistance in building economic models. Automation could reduce the substantial expertise these models demand.

Language Models In Evidence Synthesis

Research examines automated assistance with reviewing and extracting published evidence. Evidence synthesis is a major and repeated cost in evaluation.

Living Evidence And Model Maintenance

Doctoral work studies keeping evaluations current as new evidence appears. Static evaluations become misleading as the evidence base develops.

Uncertainty Communication To Decision Makers

Research investigates presentation of economic uncertainty to those making decisions. Presentation format strongly affects the decisions that follow.

Behavioural Aspects Of Payer Decisions

Doctoral study addresses psychological factors in reimbursement decision making. Decisions depart systematically from the formal frameworks used to justify them.

Ethics Of Pricing Decisions

Research examines moral questions raised by pricing life saving therapies. Pricing decisions allocate access to survival across populations.

Conflict Of Interest In Economic Research

Doctoral work studies effects of funding sources on economic conclusions. Sponsored evaluations reach favourable conclusions markedly more often.

Industry Funding And Published Estimates

Research investigates how funding relationships shape published cost figures. Estimate provenance is essential context for interpreting any figure.

Public Understanding Of Development Cost

Doctoral study addresses public and political beliefs about medicine development expenditure. Public understanding shapes the political feasibility of pricing policy.

Political Economy Of Medicine Pricing

Research examines the political forces shaping pricing and reimbursement policy. Policy outcomes reflect bargaining power as much as economic analysis.

Comparative Health System Analysis

Doctoral work studies how differing system designs affect medicine expenditure. Cross system comparison reveals which arrangements control expenditure effectively.

Forecasting Of Sector Expenditure

Research investigates projection of future medicine expenditure for health systems. Forecasts inform budget planning and policy intervention timing.

Sustainability Of Innovation Funding

Doctoral study addresses whether current arrangements can sustain continued innovation. Sustainability concerns arise from both payer and developer perspectives.

Workforce And Capability In Health Economics

Research examines the supply of skills required for economic evaluation. Capability shortages limit evaluation particularly in less wealthy systems.